Study Summary
This trial is designed to improve regulation of blood pressure by using a lottery incentive program to promote adherence to antihypertensive medication delivered via smartphone.
- Hypertension
- Hypertensive disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Baseline, 6 months, and 12 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Regret lottery
1 of 2
Control Condition
1 of 2
Experimental Treatment
Non-Treatment Group
435 Total Participants · 2 Treatment Groups
Primary Treatment: Regret Lottery · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 31st, 2021
Last Reviewed: November 20th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| New York | 66.7% |
| California | 33.3% |
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 50.0% |
| Did not meet criteria | 50.0% |